Literature DB >> 11532843

Drug points: Hypersensitivity reaction to balsalazide.

V Adhiyaman1, A Vaishnavi, S Froese.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11532843      PMCID： PMC48136          DOI： 10.1136/bmj.323.7311.489

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Mesalazine induced lupus-like syndrome.

Authors:  M T Pent; S Ganapathy; C D Holdsworth; K C Channer
Journal:  BMJ       Date:  1992-07-18

2.  Pericardial effusion during treatment with 5-aminosalicylic acid in a patient with Crohn's disease.

Authors:  H Jenss; E W Becker; P Weber
Journal:  Am J Gastroenterol       Date:  1990-03       Impact factor: 10.864

3.  Sulphasalazine-induced lupus syndrome in ulcerative colitis.

Authors:  I D Griffiths; S P Kane
Journal:  Br Med J       Date:  1977-11-05

4.  Sulphasalazine-induced lupus-like syndrome with cardiac tamponade in a patient with ulcerative colitis.

Authors:  G Deboever; R Devogelaere; G Holvoet
Journal:  Am J Gastroenterol       Date:  1989-01       Impact factor: 10.864

5.  Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.

Authors:  F M Habal; G R Greenberg
Journal:  Am J Gastroenterol       Date:  1988-01       Impact factor: 10.864
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.